Grantham, Mayo, Van Otterloo & Co (GMO)
EXEL icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Exelixis EXEL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,235
Closed -$1.64M – 678
2026
Q1 		$1.64M Sell
38,235
-30,223
-44% -$1.3M ﹤0.01% 455
2025
Q4 		$3M Buy
68,458
+56,609
+478% +$2.34M 0.01% 373
2025
Q3 		$489K Buy
+11,849
New +$476K ﹤0.01% 528
2025
Q1 		– Sell
-151,153
Closed -$5.03M – 641
2024
Q4 		$5.03M Buy
151,153
+67,256
+80% +$2.18M 0.02% 302
2024
Q3 		$2.18M Buy
+83,897
New +$2.09M 0.01% 366
2023
Q1 		– Sell
-97,100
Closed -$1.56M – 720
2022
Q4 		$1.56M Buy
97,100
+75,200
+343% +$1.23M 0.01% 464
2022
Q3 		$343K Buy
21,900
+3,800
+21% +$73.4K ﹤0.01% 614
2022
Q2 		$377K Buy
+18,100
New +$373K ﹤0.01% 642
2018
Q3 		– Sell
-31,000
Closed -$667K – 547
2018
Q2 		$667K Buy
31,000
+4,700
+18% +$97.2K ﹤0.01% 432
2018
Q1 		$583K Buy
+26,300
New +$727K ﹤0.01% 462

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s EXEL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 38,235 shares — an estimated $1.64M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EXEL in Q1 2018 and held it in 10 quarters. The position peaked at $5.03M in Q4 2024. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 38,235 Exelixis shares in Q2 2026, an estimated $1.64M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Exelixis in Q1 2018 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Exelixis position peaked at $5.03M in Q4 2024.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.